This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2005 Jun;1(2):110-4.

doi: 10.1016/j.nano.2005.03.008.

A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis

Esther H Lim¹, Narasimhan Danthi, Mark Bednarski, King C P Li

Affiliations

PMID: 17292065
DOI: 10.1016/j.nano.2005.03.008

Review

A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis

Esther H Lim et al. Nanomedicine. 2005 Jun.

. 2005 Jun;1(2):110-4.

doi: 10.1016/j.nano.2005.03.008.

Authors

Esther H Lim¹, Narasimhan Danthi, Mark Bednarski, King C P Li

Affiliation

¹ Clinical Center, National Institutes of Health, Bethesda, Maryland, USA. ElimH@cc.nih.gov

PMID: 17292065
DOI: 10.1016/j.nano.2005.03.008

No abstract available

PubMed Disclaimer

Similar articles

A concise review of current radiopharmaceuticals in tumor angiogenesis imaging.
Lu X, Wang RF. Lu X, et al. Curr Pharm Des. 2012;18(8):1032-40. doi: 10.2174/138161212799315812. Curr Pharm Des. 2012. PMID: 22272823 Review.
Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis.
Kumar CC. Kumar CC. Curr Drug Targets. 2003 Feb;4(2):123-31. doi: 10.2174/1389450033346830. Curr Drug Targets. 2003. PMID: 12558065 Review.
Imaging in drug development.
Herbst RS. Herbst RS. Clin Adv Hematol Oncol. 2004 May;2(5):268-9. Clin Adv Hematol Oncol. 2004. PMID: 16163191 No abstract available.
Radiopharmaceuticals for targeting the angiogenesis marker alpha(v)beta(3).
McQuade P, KnIght LC. McQuade P, et al. Q J Nucl Med. 2003 Sep;47(3):209-20. Q J Nucl Med. 2003. PMID: 12897712 Review.
Can contrast-enhanced US with targeted microbubbles monitor the response to antiangiogenic therapies?
Kruskal JB. Kruskal JB. Radiology. 2008 Feb;246(2):339-40. doi: 10.1148/radiol.2462071720. Radiology. 2008. PMID: 18227533 No abstract available.

See all similar articles

Cited by

Tumor angiogenic endothelial cell targeting by a novel integrin-targeted nanoparticle.
Xie J, Shen Z, Li KC, Danthi N. Xie J, et al. Int J Nanomedicine. 2007;2(3):479-85. Int J Nanomedicine. 2007. PMID: 18019845 Free PMC article.
Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivo.
Tsiapa I, Loudos G, Fragogeorgi EA, Bouziotis P, Psimadas D, Xanthopoulos S, Paravatou-Petsotas M, Palamaris L, Varvarigou AD, Karnabatidis D, Kagadis GC. Tsiapa I, et al. Cancer Biother Radiopharm. 2014 Dec;29(10):444-50. doi: 10.1089/cbr.2014.1672. Cancer Biother Radiopharm. 2014. PMID: 25405951 Free PMC article.
Integrins in angiogenesis and lymphangiogenesis.
Avraamides CJ, Garmy-Susini B, Varner JA. Avraamides CJ, et al. Nat Rev Cancer. 2008 Aug;8(8):604-17. doi: 10.1038/nrc2353. Epub 2008 May 22. Nat Rev Cancer. 2008. PMID: 18497750 Free PMC article. Review.
Inorganic nanomaterials for tumor angiogenesis imaging.
Liu Z, Peng R. Liu Z, et al. Eur J Nucl Med Mol Imaging. 2010 Aug;37 Suppl 1:S147-63. doi: 10.1007/s00259-010-1452-y. Eur J Nucl Med Mol Imaging. 2010. PMID: 20461373 Review.
Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT.
Zhou Y, Chakraborty S, Liu S. Zhou Y, et al. Theranostics. 2011 Jan 18;1:58-82. doi: 10.7150/thno/v01p0058. Theranostics. 2011. PMID: 21547153 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science